RISHAB (6)
| Date | Circular | Tags | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
BSE revises the list of securities transferred to T/XT and MT/TS groups under trade-to-trade settlement, affecting 33 scrips in main board … | |||||||||||||||
BSE revises the list of securities transferred to T/XT and MT/TS groups under trade-to-trade settlement, affecting 33 scrips in main board and 12 scrips in SME segment.
| |||||||||||||||
Open offer by Mr. Vatsal Agarwaal, Nextera Global Private Limited, and Ms. Manavika Rishiraj Agarwal to acquire up to 26% voting capital of … | |||||||||||||||
Open offer by Mr. Vatsal Agarwaal, Nextera Global Private Limited, and Ms. Manavika Rishiraj Agarwal to acquire up to 26% voting capital of Rishab Special Yarns Limited at ₹13.00 per share following indirect acquisition of control.
| |||||||||||||||
RISHAB SPECIAL YARNS LIMITED (scrip code: 514177) to be migrated from Group P to Group X with compulsory demat settlement and market lot … | |||||||||||||||
RISHAB SPECIAL YARNS LIMITED (scrip code: 514177) to be migrated from Group P to Group X with compulsory demat settlement and market lot change from 100 to 1 equity share effective November 14, 2025.
| |||||||||||||||
BSE announces movement of 17 securities into GSM Stage I and II surveillance measures effective immediately. | |||||||||||||||
BSE announces movement of 17 securities into GSM Stage I and II surveillance measures effective immediately.
| |||||||||||||||
BSE announces movement of 17 securities into different stages of Graded Surveillance Measure framework for enhanced monitoring. | |||||||||||||||
BSE announces movement of 17 securities into different stages of Graded Surveillance Measure framework for enhanced monitoring.
| |||||||||||||||
17 securities moved to different GSM stages with 11 securities entering Stage I and 6 securities entering Stage II for enhanced monitoring. | |||||||||||||||
17 securities moved to different GSM stages with 11 securities entering Stage I and 6 securities entering Stage II for enhanced monitoring.
| |||||||||||||||